ESR1 and breast carcinoma: The gene expression signature successfully identified patients with poor survival among those with ER-positive and positive axillary lymph node involvement in breast cancer within the training data set 1 (p < 0.05 and < 0.001 for ER-and lymph node positive respectively; Figure 6B and 7B).